Jan 7, 2022 by Kody Kester3 Reasons to Buy McCormick Stock and 1 Reason to SellThe consumer staple is a blue-chip dividend stock. But is the company's valuation too steep?
Jan 7, 2022 by Kody Kester3 Reasons to Buy This Dividend KingThe reasons to buy Procter & Gamble go beyond its reputation as a Dividend King.
Jan 6, 2022 by Kody Kester3 Dow Stocks to Buy Hand Over Fist in JanuaryThese Dow stocks provide investors with safe and growing payouts at reasonable valuations.
Jan 5, 2022 by Kody KesterBuying These 3 Robinhood Stocks Could Be the Smartest Investing Move You Ever MakeEach of these three stocks should continue to do well over the long haul.
Jan 5, 2022 by Kody KesterWhat Does This Label Expansion Mean for Amgen's Shareholders?The U.S. Food and Drug Administration recently approved Amgen's Otezla to treat all severity levels of plaque psoriasis.
Jan 4, 2022 by Kody KesterThis Big Pharma Stock Is Enriching Shareholders With Its Dividend. But Is It a Buy?Bristol Myers Squibb is rewarding its shareholders with a huge dividend hike and a massive share-buyback program.
Jan 3, 2022 by Kody KesterWhat Does This Regulatory News Mean for Bristol Myers Squibb's Shareholders?The U.S. Food and Drug Administration recently acknowledged Bristol Myers Squibb's application for deucravacitinib to treat moderate-to-severe psoriasis.
Jan 3, 2022 by Kody KesterPfizer Snagged Another Approval for This Immunology DrugThe Food and Drug Administration just gave the nod to Xeljanz to treat patients with ankylosing spondylitis.
Jan 2, 2022 by Kody KesterCould This FDA Approval Create a Blockbuster Drug for AbbVie?Immunology medicine Rinvoq was green-lit to treat patients with psoriatic arthritis in the U.S.
Jan 1, 2022 by Kody KesterThese 3 Stocks Just Hiked Their Dividends: Should You Buy Them?All three companies rewarded shareholders with significant payout increases.
Dec 30, 2021 by Kody Kester3 Reasons to Buy This Ultra-High-Yield Dividend StockAltria Group isn't limited to simply a market-crushing payout.
Dec 29, 2021 by Kody KesterIs This Blue Chip Retail REIT a Buy?STORE Capital is set to produce much better operating results next year.
Dec 28, 2021 by Kody KesterShould You Buy This Beaten-Down Blue-Chip Stock?Medtronic's stock has significantly lagged the S&P 500 this year for a variety of reasons.
Dec 28, 2021 by Kody KesterIs This Iconic Dividend Growth Stock a Buy for 2022?Coca-Cola is positioned to capitalize on growth opportunities in international markets.
Dec 28, 2021 by Kody KesterWhat AbbVie's Recent Drug News Means for ShareholdersAbbVie's immunology drug Skyrizi could soon be approved in the European Union to treat patients with Crohn's disease.
Dec 27, 2021 by Kody KesterLike Dividends? Then You'll Love Hershey StockHershey's portfolio of well-known and loved brands should enable strong dividend growth in the future.
Dec 26, 2021 by Kody KesterShould You Buy This Fast-Growing 5G Dividend Stock?American Tower is the leader in the rapidly expanding global telecom tower market. But is it a buy at its current valuation?
Dec 24, 2021 by Kody Kester3 Best Buffett Stocks to Buy for the Long HaulEach of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.
Dec 22, 2021 by Kody Kester4 Reasons Dividend Investors Will Love McDonald's StockThe fast-food giant offers income investors plenty of things to appreciate.
Dec 20, 2021 by Kody Kester3 Healthcare Stocks That Could Help Make You a FortuneThese three stocks are leaders in their respective fields within the vast healthcare industry.
